The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
The fifth firm in the running is Ashurst which, contrary to market speculation, has ended up on the short-list to advise on deals worth more than €100m (£67.3m).
Normally recognised for its highly regarded banking practice, A&O’s presence on the tender list is a boost to its private equity group. In February this year, A&O acted for Apax and newco Medeus Pharma on the $120m (£66.5m) acquisition of Elan Corporation’s European sales and marketing business.
A question mark still remains over which firms are in the frame to advise Apax’s leveraged transaction team on high yield. It is understood there is just one place up for grabs in the area. If A&O fails to make the panel after tendering takes place in mid-April, its expertise in high yield could still give it a shoe-in to Apax.
Apax was unavailable for comment. Ashurst and A&O declined to comment.